![Andrew Newland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Newland
Oprichter bij
Novocellus Ltd.
Vermogen: 125 348 $ op 31-07-2026
Profiel
Mr. Andrew D.
Newland is a Chairman at NeuroTargets Ltd., a Chairman at Novocellus Ltd. and a Chairman at Parsortix, Inc. He is on the Board of Directors at ANGLE Europe Ltd. and Arenko Cleantech Ltd. Mr. Newland was previously employed as a Chief Executive Officer by ANGLE Plc, a Chairman by Provexis Ltd., and a Chairman by Acolyte Biomedica Ltd. He received his graduate degree from the University of Cambridge.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CELLBXHEALTH PLC 0,64% | 31-12-2025 | 7.304.686 ( 0,64% ) | 125 348 $ | 31-07-2026 |
Actieve functies van Andrew Newland
| Bedrijven | Functie | Begin |
|---|---|---|
NeuroTargets Ltd.
 NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutic products | Voorzitter | - |
Novocellus Ltd. | Oprichter | - |
Parsortix, Inc. | Voorzitter | - |
Arenko Cleantech Ltd.
 Arenko Cleantech Ltd. Engineering & ConstructionIndustrial Services Builds, owns and operates energy storage assets | Directeur/Bestuurslid | - |
ANGLE Europe Ltd.
 ANGLE Europe Ltd. Internet Software/ServicesTechnology Services Operates as a technology platform that captures cells circulating in blood | Directeur/Bestuurslid | 26-04-2006 |
Eerdere bekende functies van Andrew Newland
| Bedrijven | Functie | Einde |
|---|---|---|
| CELLBXHEALTH PLC | Oprichter | 12-09-2025 |
Provexis Ltd.
 Provexis Ltd. BiotechnologyHealth Technology Develops and produces natural bioactive ingredients | Voorzitter | 01-01-2005 |
Acolyte Biomedica Ltd.
 Acolyte Biomedica Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures, and markets microbiology and cell enumeration systems | Oprichter | - |
Opleiding van Andrew Newland
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
45
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
CelLBxHealth Plc
 CelLBxHealth Plc Medical DistributorsDistribution Services Operates as a holding company with interests in providing products in cancer diagnostics and foetal health | Distribution Services |
Provexis Ltd.
Provexis Ltd. BiotechnologyHealth Technology Develops and produces natural bioactive ingredients | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acolyte Biomedica Ltd.
Acolyte Biomedica Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures, and markets microbiology and cell enumeration systems | Commercial Services |
NeuroTargets Ltd.
NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutic products | Health Technology |
Novocellus Ltd. | |
Parsortix, Inc. | |
Arenko Cleantech Ltd.
Arenko Cleantech Ltd. Engineering & ConstructionIndustrial Services Builds, owns and operates energy storage assets | Industrial Services |
ANGLE Europe Ltd.
ANGLE Europe Ltd. Internet Software/ServicesTechnology Services Operates as a technology platform that captures cells circulating in blood | Technology Services |
